Life Sciences Group Of The Year: Paul Hastings
Paul Hastings LLP convinced the U.S. Patent Trial and Appeal Board to invalidate a major patent covering AbbVie's $16 billion biologic Humira and uphold four patents covering an Acorda Therapeutics Inc....To view the full article, register now.
Already a subscriber? Click here to view full article